IRINOTECAN Fresenius conc perf 300 mg/15ml 15 ml
7680612460190
CH-61246
L01XX19
07.16.1.
1 / 3
google
Details
- Product number
- 6124603
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- irinotecani hydrochloridum trihydricum 300 mg, sorbitolum 675 mg, acidum lacticum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 15 ml.
Articles (1)
Irinotecan Fresenius 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
675.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 283.55
Specialties list
Yes
Generic
Yes
SL addition date:
01/12/2011
Authorization holder
Fresenius Kabi (Schweiz) AG
6010 Kriens
Authorization information
- Swissmedic authorization number
- 61246
- Drug name
- Irinotecan Fresenius, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01XX19
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 28/01/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- IRINOTECAN Fresenius conc perf 300 mg/15ml 15 ml
- Description (DE)
- IRINOTECAN Fresenius Inf Konz 300 mg/15ml 15 ml
- Market launch
- 28/01/2011
- Narcotic (BTM)
- No